Results 151 to 160 of about 1,624 (170)
Some of the next articles are maybe not open access.
Molecular Cell
Metabolic reprogramming is an important feature of cancers that has been closely linked to post-translational protein modification (PTM). Lysine succinylation is a recently identified PTM involved in regulating protein functions, whereas its regulatory mechanism and possible roles in tumor progression remain unclear. Here, we show that OXCT1, an enzyme
Ronghui Yan, Pinggen Zhang, Zilong Zhou
exaly +3 more sources
Metabolic reprogramming is an important feature of cancers that has been closely linked to post-translational protein modification (PTM). Lysine succinylation is a recently identified PTM involved in regulating protein functions, whereas its regulatory mechanism and possible roles in tumor progression remain unclear. Here, we show that OXCT1, an enzyme
Ronghui Yan, Pinggen Zhang, Zilong Zhou
exaly +3 more sources
Neuroprotective mechanisms of OXCT1 via the SIRT3-SOD2 pathway after traumatic brain injury
Brain Research, 2023Ketones are not only utilized to produce energy but also play a neuroprotective role in many neurodegenerative diseases. However, whether this process has an impact on secondary brain damage after traumatic brain injury (TBI) remains unknown. OXCT1 (3-Oxoacid CoA-Transferase 1) is the rate-limiting enzyme in the intra-neuronal utilization of ketones ...
Yun-Song Zhuang +9 more
openaire +2 more sources
OXCT1 Succinylation and Activation by SUCLA2 Promotes Ketolysis and Liver Tumor Growth
Molecular CellKetone bodies generated in hepatocytes in the adult liver are used for nonhepatic tissues as an energy source. However, ketolysis is reactivated in hepatocellular carcinoma (HCC) cells with largely unelucidated mechanisms. Here, we demonstrate that 3-oxoacid CoA-transferase 1 (OXCT1), a rate-limiting enzyme in ketolysis, interacts with SUCLA2 upon IGF1
Zhimin Lu, Guijun Liu, Xuxiao He
exaly +3 more sources
3-Oxoacid CoA-transferase 1 (OXCT1) plays a crucial role in hepatocellular carcinoma (HCC) progression through its ketolytic and succinyltransferase activities. Despite its potential as a therapeutic target, no small molecules have been developed to inhibit the dual enzymatic activities of OXCT1 specifically.
Zilong Zhou, Nanchi Xiong, Xue Ai
exaly +3 more sources
Human Mutation, 2013
The molecular basis of simultaneous two-exon skipping induced by a splice-site mutation has yet to be completely explained. The splice donor site mutation c.1248+5g>a (IVS13) of the OXCT1 gene resulted predominantly in skipping of exons 12 and 13 in fibroblasts from a patient (GS23) with succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency.
Tomohiro, Hori +5 more
openaire +2 more sources
The molecular basis of simultaneous two-exon skipping induced by a splice-site mutation has yet to be completely explained. The splice donor site mutation c.1248+5g>a (IVS13) of the OXCT1 gene resulted predominantly in skipping of exons 12 and 13 in fibroblasts from a patient (GS23) with succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency.
Tomohiro, Hori +5 more
openaire +2 more sources
Gene, 2012
In the mitochondrial matrix, the OXCT1 gene catalyzes the reversible transfer of coenzyme A from succinyl-CoA to acetoacetate in a reaction related to energy production from ketone bodies. Here, horse OXCT1 gene containing coenzyme A transferase domain was identified in the transcriptome analysis of cDNAs derived from skeletal muscles. Horse OXCT1 gene
Gyu-Hwi, Nam +10 more
openaire +2 more sources
In the mitochondrial matrix, the OXCT1 gene catalyzes the reversible transfer of coenzyme A from succinyl-CoA to acetoacetate in a reaction related to energy production from ketone bodies. Here, horse OXCT1 gene containing coenzyme A transferase domain was identified in the transcriptome analysis of cDNAs derived from skeletal muscles. Horse OXCT1 gene
Gyu-Hwi, Nam +10 more
openaire +2 more sources
Friedreich’s ataxia is a genetic disease caused by a mutation in the gene (FXN chromosome 9). It is an excessive repetition of the GAA codon, which prevents the expression of the frataxin protein. This protein ensures the functioning of the respiratory complexes of the mitochondria, by providing them with the iron/sulfur clusters they need to
Maurice Israël
exaly +2 more sources
Cell Cycle, 2023
Previous study has demonstrated the high expression of circular RNA 3-oxoacid CoA-transferase 1 (circ-OXCT1) in lung adenocarcinoma tumor tissues. However, the role and possible mechanism of circ-OXCT1 in non-small cell lung cancer (NSCLC) progression was unclear.Quantitative real-time PCR (qRT-PCR), western blotting and immunohistochemistry (IHC ...
Hua, Luo, Jianming, Peng, Yuexi, Yuan
exaly +3 more sources
Previous study has demonstrated the high expression of circular RNA 3-oxoacid CoA-transferase 1 (circ-OXCT1) in lung adenocarcinoma tumor tissues. However, the role and possible mechanism of circ-OXCT1 in non-small cell lung cancer (NSCLC) progression was unclear.Quantitative real-time PCR (qRT-PCR), western blotting and immunohistochemistry (IHC ...
Hua, Luo, Jianming, Peng, Yuexi, Yuan
exaly +3 more sources
Two Anti-Sense Non-Coding RNAs Regulate Their Sense Gene mRNAs: OXCT1–SCOT for Ketolysis and FGF 14 an Anti-Proliferation Factor, in Cancer [PDF]
Maurice Israël
exaly +2 more sources
Nuclear OXCT1 attenuates histone β-hydroxybutyrylation-mediated MHC-I transcription
Nature Chemical BiologyUnderstanding of the metabolic determinants influencing immunotherapy responsiveness remains limited. Here we performed a multiomics analysis of tumor biopsies from patients with hepatocellular carcinoma (HCC) treated with immune checkpoint blockade (ICB) and revealed that heightened expression of OXCT1, a rate-limiting enzyme in ketone body metabolism,
Zhiqiang Hu +27 more
openaire +2 more sources

